STAA - CIK 0000718937
The table below shows STAAR SURGICAL CO's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2026 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$34.23M | $15.72M | $14.59M | $35.72M | $43.96M | $20.95M |
| Capital expenditure | $5.82M | $23.39M | $18.19M | $18.11M | $13.64M | $8.40M |
| Investing cash flow | $46.34M | -$59.22M | $74.35M | -$156.38M | -$13.64M | -$8.40M |
| Dividends paid | - | - | - | - | - | - |
STAAR SURGICAL CO reported operating cash flow of -$34.23M for fiscal year 2026. That is down 317.7% from $15.72M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from $1.05M (FY 2016) to -$34.23M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Stock buybacks | $6.46M | - | - | - | - | - |
| Financing cash flow | -$4.55M | $5.72M | $7.42M | $8.30M | $17.79M | $19.57M |